An insider trading-shaped bone. Allergan Inc, which is fighting a $51 billion hostile takeover bid from Valeant Pharmaceuticals International and activist investor William Ackman, on Friday filed a federal lawsuit alleging they violated insider trading laws and engaged in other fraudulent practices. The suit alleges that Ackman’s hedge fund, Pershing Square Capital Management between February…